Bitcoin rallied above $68,500 after US stocks turned green on US policy clarity and strong earnings results. Will bulls target $70,000 next?

Market AnalysisRead More

You might also be interested in reading Day One Biopharmaceuticals outlines $140M–$150M 2025 OJEMDA revenue target as new patient scripts accelerate.